Yes we've developed a vaccine prototype and we are raising funds for the final experiment before we start working with the FDA to file our IND and start working on our phase I clinical trial. In terms of testing on humans, the first thing you do is dose healthy volunteers and withdraw a blood sample to test for an immune response. Then assuming success in phase I, in a phase II trial we will dose high risk healthy volunteers and see if they get HIV over a time interval.